Cerissa French profile page

Cerissa French graduated with a BA (Hons) in biomedical science from Griffith University, Gold Coast. After a brief time working in a drug discovery start up, French moved into the commercial side of science, working for Invitrogen as a sales specialist before taking on a business development role at Roche Diagnostics to build the next-generation sequencing and microarray business in Australia. During this time, French completed an Executive MBA at Queensland University of Technology. After 7 years at Roche, she relocated to Germany and has spent most of the last 11 years working across Europe in specialist roles for NGS and microarray technologies for Affymetrix and Illumina. Her passion is seeing novel technologies deployed in the clinic, which has led to her role at Oxford Nanopore Technologies, where she is responsible for bringing this novel sequencing technology to the clinic.